Cargando…
Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats
BACKGROUND: Cushing’s syndrome is an endocrine disorder characterized by the overproduction of adrenocortical steroids. Steroidogenesis enzyme inhibitors are the mainstays of pharmacological treatment. Unfortunately, they produce significant side effects. Among the most potent inhibitors is the gene...
Autores principales: | McGrath, Megan, Hofmann, Alissa, Raines, Douglas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683373/ https://www.ncbi.nlm.nih.gov/pubmed/31383012 http://dx.doi.org/10.1186/s40360-019-0328-4 |
Ejemplares similares
-
Pharmacological management of severe Cushing’s syndrome: the role of etomidate
por: Pence, Andrea, et al.
Publicado: (2022) -
The etomidate analog ET-26 HCl retains superior myocardial performance: Comparisons with etomidate in vivo and in vitro
por: Liu, Xingxing, et al.
Publicado: (2018) -
Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics
por: Valk, Beatrijs I., et al.
Publicado: (2021) -
Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate
por: Ge, Rile, et al.
Publicado: (2013) -
Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats
por: Jiang, Junli, et al.
Publicado: (2017)